OPTIMA PHARMA
Annual accounts 2020
full format, filed on 02-06-2022, 306 days lateMoney flows
no detail for 2020Balance sheet
balance sheet total €6.6m on 31-12-2020in euro
in euro
Position in the sector
6.9%
Higher than 11% of 3,667 companies in 2020.
1.07
Higher than 21% of 3,632 companies in 2020.
6.0%
Higher than 56% of 3,653 companies in 2020.
Net result: top quarter · Equity: middle half · Balance sheet total: top quarter · Working capital: top quarter
Staff
Staff costs divided by the average number of full-time equivalents.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | ||||||||
20/58 |
6.6m | 297,370 | 216,983 | 105,736 | 127,802 | 27,845 | 46,551 | |
21/28 |
50,202 | 39,110 | 35,000 | 35,000 | 20,000 | - | - | |
22/27 |
8,243 | - | - | - | - | - | - | |
24 |
8,243 | - | - | - | - | - | - | |
28 |
41,960 | 39,110 | 35,000 | 35,000 | 20,000 | - | - | |
29/58 |
6.6m | 258,260 | 181,983 | 70,736 | 107,802 | 27,845 | 46,551 | |
29 |
70,000 | 70,000 | - | - | - | - | - | |
290 |
70,000 | 70,000 | - | - | - | - | - | |
3 |
30,000 | - | - | - | - | - | - | |
30/36 |
30,000 | - | - | - | - | - | - | |
40/41 |
6.3m | 187,000 | 178,068 | 67,354 | 107,721 | 3,493 | 35,460 | |
40 |
5.9m | 174,595 | 81,968 | 1,624 | 51,296 | 2,836 | 35,460 | |
41 |
370,091 | 12,405 | 96,100 | 65,731 | 56,425 | 657 | - | |
50/53 |
80,582 | - | - | - | - | 4 | 4 | |
54/58 |
118,058 | 153 | 3,767 | 2,821 | 81 | 24,348 | 11,087 | |
490/1 |
55 | 1,107 | 148 | 561 | - | - | - | |
| Balance sheet: equity and liabilities | ||||||||
10/49 |
6.6m | 297,370 | 216,983 | 105,736 | 127,802 | 27,845 | 46,551 | |
10/15 |
458,814 | 59,786 | 19,040 | -191,110 | -34,059 | 2,029 | 24,926 | |
10/11 |
6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | |
100 |
- | 18,600 | 18,600 | 18,600 | 18,600 | 18,600 | 18,600 | |
101 |
- | 12,400 | 12,400 | 12,400 | 12,400 | 12,400 | 12,400 | |
14 |
452,614 | 53,586 | 12,840 | -197,310 | -40,259 | -4,171 | 18,726 | |
17/49 |
6.2m | 237,584 | 197,943 | 296,846 | 161,861 | 25,816 | 21,625 | |
42/48 |
6.2m | 236,899 | 197,943 | 296,846 | 161,861 | 25,816 | 21,625 | |
43 |
- | - | 15,847 | 19,040 | 56,987 | 14,965 | - | |
430/8 |
- | - | 15,847 | 19,040 | 56,987 | 14,965 | - | |
44 |
5.7m | 45,536 | 92,193 | 54,560 | 29,472 | 5,739 | 15,628 | |
440/4 |
5.7m | 45,536 | 92,193 | 54,560 | 29,472 | 5,739 | 15,628 | |
45 |
407,017 | 150,958 | 59,016 | 52,077 | 23,768 | 5,112 | 5,997 | |
450/3 |
384,020 | 141,217 | 49,665 | 47,236 | - | - | 885 | |
454/9 |
22,997 | 9,741 | 9,351 | 4,842 | 23,768 | 5,112 | 5,112 | |
47/48 |
97,000 | 40,405 | 30,887 | 171,167 | 51,633 | - | - | |
492/3 |
- | 685 | - | - | - | - | - | |
| Income statement | ||||||||
70 |
- | - | 323,974 | 127,632 | - | - | - | |
9900 |
880,959 | 102,501 | 215,593 | -67,089 | 16,350 | -22,897 | 18,796 | |
60/61 |
- | - | 108,381 | 247,494 | - | - | - | |
62 |
111,261 | 20,098 | -1 | 25,324 | 49,755 | - | - | |
630 |
1,501 | - | - | - | - | - | - | |
631/4 |
215,500 | - | - | - | - | - | - | |
640/8 |
- | 8,225 | 1,710 | 30,653 | 1,154 | - | - | |
66A |
- | 5,546 | - | - | - | - | - | |
9901 |
552,697 | 68,632 | 213,884 | -123,066 | -34,559 | -22,897 | 18,796 | |
75/76B |
3,759 | 5,093 | 7,533 | 4,608 | 410 | - | - | |
75 |
3,759 | 5,093 | 7,533 | 4,608 | 410 | - | - | |
65/66B |
2,237 | 6,740 | 5,562 | 38,593 | 1,939 | 0 | 69 | |
65 |
2,237 | 6,740 | 5,562 | 11,796 | 1,939 | 0 | 69 | |
66B |
- | - | 0 | 26,798 | - | - | - | |
9903 |
554,219 | 66,984 | 215,855 | -157,051 | -36,088 | -22,897 | 18,726 | |
67/77 |
156,000 | 25,430 | 5,705 | - | - | - | - | |
9904 |
398,219 | 41,554 | 210,150 | -157,051 | -36,088 | -22,897 | 18,726 | |
9905 |
398,219 | 41,554 | 210,150 | -157,051 | -36,088 | -22,897 | 18,726 | |
| Appropriation of the result | ||||||||
9906 |
452,614 | 54,394 | 12,840 | -197,310 | -40,259 | -4,171 | 18,726 | |
14P |
54,394 | - | - | - | - | - | - | |
694/7 |
- | 808 | - | - | - | - | - | |
694 |
- | 808 | - | - | - | - | - | |
| Social balance sheet | ||||||||
9087 |
- | - | - | 0.3 | - | - | - | |
Hours worked1013 |
- | - | - | 441 | - | - | - | |
| Document | ||||||||
The notes to these accounts have 8 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).
Source: Annual accounts 2020 (PDF), filed on 02-06-2022.
Filings
each dot is a set of accounts, on the day it reached the National Bank2020 annual accounts filed 306 days after the deadline. Filed on 2 June 2022, deadline 31 July 2021 (7 months after the close on 31 December 2020, Companies Code art. 3:10). Source: NBB, 2022-20045012.
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2020 | full format | 02-06-2022 | 2022-20045012 | |
| 31-12-2019 | full format | 25-08-2020 | 2020-43800568 | |
| 31-12-2018 | micro format | 14-10-2019 | 2019-70600451 | |
| 31-12-2017 | micro format | 27-11-2018 | 2018-73000600 | |
| 31-12-2016 | micro format | 30-08-2017 | 2017-55200304 | |
| 31-12-2015 | full format | 07-11-2016 | 2016-67500596 | |
| 31-12-2014 | full format | 22-07-2015 | 2015-34200423 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
| 554,198 | - | - | - | - | - | - | ||
| 399,721 | - | - | - | - | - | - | ||
| 12,594 | 4,110 | - | 17,600 | 20,000 | - | - | ||
| 117,905 | -3,614 | 946 | 2,740 | -24,267 | 13,261 | - | ||
| 408,611 | 21,362 | -15,960 | -226,110 | -54,059 | 2,029 | 24,926 | ||
| - | - | 66.0% | -96.4% | - | - | - | ||
| 6.9% | 20.1% | 8.8% | -180.7% | -26.6% | 7.3% | 53.5% | ||
| 1.07 | 1.09 | 0.92 | 0.24 | 0.67 | 1.08 | 2.15 | ||
| 1.06 | 1.09 | 0.92 | 0.24 | 0.67 | 1.08 | 2.15 | ||
| 13.48 | 3.97 | 10.40 | - | - | 12.72 | 0.87 | ||
| 86.8% | 69.5% | - | - | - | - | 75.1% | ||
| 6.0% | 14.0% | 96.9% | -148.5% | -28.2% | -82.2% | 40.2% | ||
| over 100 | - | - | - | - | - | - | ||
| - | - | 92 days | 5 days | - | - | - | ||
| - | - | 310 days | 80 days | - | - | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2020 |
|---|---|
| Tangible fixed assets | €9,744 |
| Financial fixed assets | €2,850 |
| €1,501 |
Source: notes to the 2020 annual accounts (statement of fixed assets)
Insights on OPTIMA PHARMA
The operating result for 2020 is nearly 8.1 times that of 2019 and the highest since 2014. It is a recovery after the fall in 2019.
Debt's share of the balance-sheet total rises from 79.9% to 93.1%. Equity and debt are higher.
- 2019 Net result -80% on 2018. The accounts now follow the full format, last year the micro format.